The Council on Drug and Food Safety under the Ministry of Health, Labor and Welfare deliberated on this issue and took a positive attitude towards approval. The drug is under license from Amylin Pharmaceuticals, USA.
Nikkei Biotech, March 11, 2013
Shionogi close to approval of “Metreleptin”, a therapeutic for treatment of fat atrophy